Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...
Figure 1: Infection of blood-derived DCs with DV. In summary, our data have shown that immature blood and skin DCs are permissive for DV replication. We have also described a single in vivo case of DV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results